Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Growth 2025-2031

The global Extracorporeal Membrane Oxygenation (ECMO) Systems market size is predicted to grow from US$ 248 million in 2025 to US$ 311 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.

Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.

The Extracorporeal Membrane Oxygenation (ECMO) Systems market is primarily driven by the increasing incidence of severe respiratory and cardiac conditions, alongside advancements in critical care technologies. Conditions like acute respiratory distress syndrome (ARDS) and heart failure are on the rise, and ECMO systems provide crucial support in cases where traditional respiratory support like ventilators is insufficient. The COVID-19 pandemic further highlighted ECMO's life-saving potential, prompting healthcare providers and governments worldwide to invest in ECMO infrastructure, especially for high-acuity facilities. Additionally, advancements in ECMO technology, such as portable systems and improved oxygenators, have broadened their applicability and increased adoption in neonatal and pediatric intensive care settings, driving overall market growth.

However, the ECMO systems market faces significant challenges, particularly due to high equipment and procedural costs, which limit accessibility to larger, well-funded healthcare centers. ECMO also requires skilled professionals for operation and patient monitoring, a demand that current healthcare systems struggle to meet, especially in low- and middle-income countries. Regulatory constraints further add to the barriers, as ECMO systems undergo strict safety and efficacy evaluations that can delay market entry and increase costs for manufacturers. These challenges collectively hinder ECMO system adoption and accessibility, making it a critical yet resource-intensive technology in the healthcare industry.

LP Information, Inc. (LPI) ' newest research report, the “Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Forecast” looks at past sales and reviews total world Extracorporeal Membrane Oxygenation (ECMO) Systems sales in 2024, providing a comprehensive analysis by region and market sector of projected Extracorporeal Membrane Oxygenation (ECMO) Systems sales for 2025 through 2031. With Extracorporeal Membrane Oxygenation (ECMO) Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Extracorporeal Membrane Oxygenation (ECMO) Systems industry.

This Insight Report provides a comprehensive analysis of the global Extracorporeal Membrane Oxygenation (ECMO) Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Extracorporeal Membrane Oxygenation (ECMO) Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Extracorporeal Membrane Oxygenation (ECMO) Systems market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Extracorporeal Membrane Oxygenation (ECMO) Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Extracorporeal Membrane Oxygenation (ECMO) Systems.

This report presents a comprehensive overview, market shares, and growth opportunities of Extracorporeal Membrane Oxygenation (ECMO) Systems market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
VA (Veno-Arterial) ECMO
VV (Veno-Venous) ECMO

Segmentation by Application:
Neonatal
Pediatric
Adult

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
Getinge (Maquet)
LivaNova (Sorin)
Terumo
Fresenius Medical Care
Chinabridge(Shenzhen) Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Extracorporeal Membrane Oxygenation (ECMO) Systems market?

What factors are driving Extracorporeal Membrane Oxygenation (ECMO) Systems market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Extracorporeal Membrane Oxygenation (ECMO) Systems market opportunities vary by end market size?

How does Extracorporeal Membrane Oxygenation (ECMO) Systems break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.